Filing metadata

Accession number
0001209191-22-060093
Form type
Form 4
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
Dec 06, 2022
Reporting period
Dec 03, 2022
Description
Insider transaction

Explore SEC Filings Hub